The global rollout of COVID-19 vaccines will be the largest, fastest and most challenging vaccination program in history. This could bring many problems. Some we will anticipate; some we won’t. One glaring problem that is quickly emerging is a major mismatch between vaccine supply and demand.
A new survey by Ipsos and King's College London Policy Institute shows that one in three people in the UK (34%) say they have seen or heard messages discouraging the public from getting a coronavirus vaccine.
The UK public tend to have a negative view of anti-vaxxers, although a notable minority have a favourable perception of people who would refuse a coronavirus vaccine, a new study has found.
The success of a COVID-19 vaccine is one of the biggest challenges we face globally. This paper explores the opportunities and obstacles that lie ahead.
Our new poll shows the announcements about the COVID-19 vaccine trials have lifted the nation’s spirits, particularly amongst the youngest age groups, but some concerns remain.
COVID-19 has put the topic of vaccination centre-stage, with the expedited development of a COVID-19 vaccine viewed by many as the only real solution to the current pandemic – or at least part of it.
